Boston, MA, 11/14/2013 (nysepost) – In Wednesday’s trading session, Oxygen Biotherapeutics, Inc (NASDAQ:OXBT) dropped by 8.57%. The shares opened at a price of $6.81, which touched the intraday high of $6.90 and headed to a close of $6.40. Around 1.60 million exchanged hands over the trading day and an average volume of 5.34 million shares were traded over a 30 day period. The 52-week low of Oxygen Biotherapeutics, Inc (NASDAQ:OXBT) shares is $1.19 and its 52-week high is $20.00. The company has a market capitalization of $32.33 billion.
About the company
Oxygen Biotherapeutics, Inc (NASDAQ:OXBT) is involved in developing bio-technology products that have a primary focus on oxygen-delivery to tissue. As of 30 April 30, it is developing Oxycyte. This is a systemic-perfluorcarbon product. It has developed a huge family of perfluorocarbon-based-oxygen carriers that are to be used in personal care, topical-wound healing as well as other topical indications. In addition to this, Oxygen Biotherapeutics, Inc (NASDAQ:OXBT) has under its development Vitavent. This an oxygen-exchange fluid that is used for facilitating treatment of various lung conditions & it has out licensed the rights to its biosensor-implant product that utilizes an enzyme-process for measurement of glucose level in the subcutaneous fluid.
Oxygen Biotherapeutics, Inc (NASDAQ:OXBT)’s Oxycyte oxygen carrier product is a PFC- based oil-in water emulsion. This product is given to the patient intravenously. The physical-properties of PFC allow its product to gather the oxygen from lungs and transport this oxygen through the entire body releasing it as it moves along. Over a period of few days Oxycyte slowly evaporates inside the lungs from where it is later exhaled. Oxycyte is provided as this sterile emulsion that ready for intravenous-administration.
Oxygen Biotherapeutics, Inc (NASDAQ:OXBT)’s Dermacyte line of topical-cosmetic products employ its PFC technology & other known cosmetic -ingredients to promote appearance of skin-health and other desirable-cosmetic benefits.